Unnamed: 0,title,date,stock,sentiment
928680.0,Neovasc Shares Volatile Following Press Release Highlighting Co.'s Reducer Was Spotlighted In Leading German Public TV Program,2020-06-03 09:54:00-04:00,NVCN,positive
928681.0,Neovasc Reports Filed For CE Mark For Tiara TA Transapical Mitral Valve Replacement System,2020-05-27 10:13:00-04:00,NVCN,neutral
928682.0,Neovasc Has Filed for CE Mark for Tiara TA Transapical Mitral Valve Replacement System,2020-05-27 09:42:00-04:00,NVCN,neutral
928683.0,"The Daily Biotech Pulse: Cumberland's Positive Anti-Bacterial Readout, FDA Nods For Bristol-Myers, Astellas",2020-05-27 07:25:00-04:00,NVCN,positive
928684.0,"Neovasc Announces Offering Of Convertible Debt And Warrants for Gross Proceeds Of Uo To $5M, Warrant Exchange Transaction And Repayment Of 2017 Convertible Notes And Related Settlement",2020-05-26 16:04:00-04:00,NVCN,negative
928685.0,CORRECTION: Neovasc Q1 Sales $532.895K,2020-05-07 17:11:00-04:00,NVCN,neutral
928686.0,"Neovasc Q1 EPS $(0.380) Misses $(0.050) Estimate, Sales $532.895K",2020-05-07 16:47:00-04:00,NVCN,negative
928687.0,Neovasc Announces Receipt Of Nasdaq Extension To Satisfy Market Cap Rule,2020-05-01 17:00:00-04:00,NVCN,positive
928688.0,33 Stocks Moving in Thursday's Pre-Market Session,2020-04-16 07:19:00-04:00,NVCN,neutral
928689.0,70 Biggest Movers From Yesterday,2020-04-16 04:38:00-04:00,NVCN,neutral
928690.0,50 Stocks Moving In Wednesday's Mid-Day Session,2020-04-15 12:35:00-04:00,NVCN,neutral
928691.0,"The Daily Biotech Pulse: Fate Therapeutics Inks Cell Therapy Deal With J&J, Zentalis IPO",2020-04-03 07:36:00-04:00,NVCN,neutral
928692.0,"The Daily Biotech Pulse: InflaRx Begins Human Testing For COVID-induced Pneumonia, Chembio, Becton Dickinson Launch Coronavirus Tests",2020-04-01 07:38:00-04:00,NVCN,neutral
928693.0,"Canaccord Genuity Maintains Buy on Neovasc, Lowers Price Target to $3",2020-03-31 11:55:00-04:00,NVCN,negative
928694.0,5 Stocks Moving In Monday's After-Hours Session,2020-03-30 16:47:00-04:00,NVCN,neutral
928695.0,"Neovasc Q4 EPS $(1.45) Down From $(0.77) YoY, Sales $565.821K Up From $523.424K YoY",2020-03-30 16:23:00-04:00,NVCN,neutral
928696.0,Neovasc shares are trading lower after the company reported Q4 earnings results.,2020-03-30 16:21:00-04:00,NVCN,neutral
928697.0,Neovasc Q4 Sales $565.821K Up From $523.424K YoY,2020-03-30 16:16:00-04:00,NVCN,neutral
928698.0,"Earnings Scheduled For March 30, 2020",2020-03-30 04:13:00-04:00,NVCN,neutral
928699.0,"The Daily Biotech Pulse: T2 Biosystems Licenses COVID-19 Test, Immuron CEO Steps Down",2020-03-25 07:29:00-04:00,NVCN,neutral
928700.0,"The Daily Biotech Pulse: Milestone Pharma Flunks Late-Stage Study, CytomX Strikes Cancer Drug Collaboration, BARDA Grant For GenMark's COVID-19 Test",2020-03-24 08:20:00-04:00,NVCN,negative
928701.0,Novocure Reports German Federal Joint Committee Updated Directive For Contracted Medical Care To Include Tumor Treating Fields,2020-03-20 09:18:00-04:00,NVCN,positive
928702.0,"The Daily Biotech Pulse: Mylan Ramps Up Manufacturing Of Potential COVID-19 Drug, Lexicon Stops Study Early, Masimo To Buy German Ventilation Company",2020-03-20 07:44:00-04:00,NVCN,negative
928703.0,"The Daily Biotech Pulse: Pfizer's Eczema Drug Aces Latestage Study, Orphan Drug Designation For Dicerna, Dyadic's COVID-19 Connection",2020-03-19 07:37:00-04:00,NVCN,neutral
928704.0,"The Daily Biotech Pulse: AbbVie, Allergan Agree On Divestments, Obalon Stops Obesity Balloon Sale, COVID-19 Updates",2020-03-18 07:36:00-04:00,NVCN,positive
928705.0,"The Daily Biotech Pulse: Setback For DBV In Peanut Allergy Patch Review, Roche Starts Coronavirus Test Shipment, Regeneron Aims For 'Cocktail' COVID-19 Treatment",2020-03-17 08:48:00-04:00,NVCN,neutral
928706.0,"The Daily Biotech Pulse: Roche Obtains FDA Emergency Use Authorization For COVID-19 Test, Chembio Appoints New CEO, Inovio Slumps On Earnings",2020-03-13 07:52:00-04:00,NVCN,negative
928707.0,"The Daily Biotech Pulse: AstraZeneca Faces Setback In Ovarian Cancer Study, Mallinckrodt To Explore COVID-19 Treatment, Imara IPO",2020-03-12 07:37:00-04:00,NVCN,negative
928708.0,"The Daily Biotech Pulse: NY State Endorses Mallinckrodt's Opioid Settlement, Kamada To Work On COVID-19 Treatment",2020-03-11 08:03:00-04:00,NVCN,positive
928709.0,"The Daily Biotech Pulse: Mesoblast To Test Candidate On Coronavirus Symptoms, Proxy Battle Ahead For Rockwell Medical, Glaukos to Join S&P SmallCap 600 Index",2020-03-10 09:19:00-04:00,NVCN,negative
928710.0,Neovasc Press Release Highlights Updates Given To Investors At SVB Leerink Healthcare Conference,2020-03-04 09:08:00-05:00,NVCN,neutral
928711.0,Neovasc Highlights Feature Of Its Reducer Device In Peer Reviewed EuroIntervention And PCR Online,2020-03-03 09:04:00-05:00,NVCN,neutral
928712.0,Neovasc Reports Will Request Nasdaq Hearing After Co. Received Expected Delisting Determination From Nasdaq Staff,2020-02-20 07:18:00-05:00,NVCN,positive
928713.0,"Neovasc Granted European Patent Number EP3020377 Titled ""APPARATUS FOR DELIVERING ENDOLUMINAL PROSTHESIS""",2020-02-19 10:38:00-05:00,NVCN,positive
928714.0,94 Biggest Movers From Yesterday,2020-02-12 05:13:00-05:00,NVCN,neutral
928715.0,71 Stocks Moving In Tuesday's Mid-Day Session,2020-02-11 12:21:00-05:00,NVCN,neutral
928716.0,Neovasc Says Has Taken Action As It Believes That There May Have Been Illegal Market Manipulation Including Possible Shorting And Distorting Of The Common Shares Of The Company,2020-02-11 07:34:00-05:00,NVCN,negative
928717.0,Neovasc Initiates Independent Inquiry Into Trading Of Its Shares,2020-02-11 07:31:00-05:00,NVCN,positive
928718.0,85 Biggest Movers From Yesterday,2020-02-04 04:56:00-05:00,NVCN,neutral
928719.0,Neovasc Announces Renewal Of German Reimbursement NUB Status 1 Designation For Neovasc Reducer For Treatment Of Refractory Angina,2020-01-31 09:03:00-05:00,NVCN,neutral
928720.0,"Neovasc Reports Executive Steering Committee For Retrievable Transfemoral Trans-Septal Tiara Program, Will Enroll First Patient In Feasibility Trial In Late 2020",2020-01-28 09:06:00-05:00,NVCN,neutral
928721.0,36 Healthcare Stocks Moving In Monday's After-Market Session,2020-01-27 23:41:00-05:00,NVCN,neutral
928722.0,4 Medical Devices Stocks Moving In Monday's After-Market Session,2020-01-27 23:33:00-05:00,NVCN,neutral
928723.0,27 Medical Devices Stocks Moving In Monday's Session,2020-01-27 12:48:00-05:00,NVCN,neutral
928724.0,Neovasc Advances New Transfemoral Trans-septal Tiara Design Concept After Further Successful Tests,2020-01-24 09:03:00-05:00,NVCN,positive
928725.0,Neovasc Highlights Presentations Across Germany Featuring Co.'s Reducer Product,2020-01-22 09:03:00-05:00,NVCN,neutral
928726.0,36 Stocks Moving In Wednesday's Mid-Day Session,2020-01-15 12:07:00-05:00,NVCN,neutral
928727.0,34 Healthcare Stocks Moving In Wednesday's Pre-Market Session,2020-01-15 08:10:00-05:00,NVCN,neutral
928728.0,21 Stocks Moving in Wednesday's Pre-Market Session,2020-01-15 07:43:00-05:00,NVCN,neutral
928729.0,Neovasc Receives Administrative Acceptance Review Notification For Premarket Approval Application From FDA For The Neovasc Reducer,2020-01-15 07:04:00-05:00,NVCN,positive
928730.0,34 Healthcare Stocks Moving In Friday's Pre-Market Session,2020-01-03 07:45:00-05:00,NVCN,neutral
928731.0,65 Biggest Movers From Yesterday,2020-01-03 04:36:00-05:00,NVCN,neutral
928732.0,Mid-Afternoon Market Update: Signet Jewelers Falls Following Wells Fargo Downgrade; Trillium Therapeutics Shares Surge,2020-01-02 14:35:00-05:00,NVCN,positive
928733.0,42 Stocks Moving In Thursday's Mid-Day Session,2020-01-02 12:13:00-05:00,NVCN,neutral
928734.0,Mid-Day Market Update: Dow Rises 170 Points; Synthesis Energy Systems Shares Jump,2020-01-02 12:05:00-05:00,NVCN,positive
928735.0,Mid-Morning Market Update: Markets Open Higher; Imagination Technologies Signs New Deal With Apple,2020-01-02 10:20:00-05:00,NVCN,neutral
928736.0,Neovasc shares are trading lower after the company announced a $10 million common stock offering priced at-the-market.,2020-01-02 09:29:00-05:00,NVCN,neutral
928737.0,Neovasc Shares To Resume Trade At 8:45 a.m. EDT,2020-01-02 08:25:00-05:00,NVCN,positive
928738.0,Neovasc Announces $10M Registered Direct Offering Priced At The Market,2020-01-02 08:25:00-05:00,NVCN,neutral
928739.0,"Neovasc Shares Halted, News Pending",2020-01-02 08:11:00-05:00,NVCN,positive
928740.0,20 Stocks Moving in Thursday's Pre-Market Session,2020-01-02 07:30:00-05:00,NVCN,neutral
928741.0,63 Biggest Movers From Tuesday,2020-01-02 05:05:00-05:00,NVCN,neutral
928742.0,"4 Stocks To Watch For January 2, 2020",2020-01-02 04:52:00-05:00,NVCN,neutral
928743.0,Mid-Afternoon Market Update: Dow Falls 40 Points; Core Laboratories Shares Slide,2019-12-31 14:25:00-05:00,NVCN,positive
928744.0,38 Stocks Moving In Tuesday's Mid-Day Session,2019-12-31 12:18:00-05:00,NVCN,neutral
928745.0,Mid-Day Market Update: Neovasc Jumps After Submitting Approval Application For Neovasc Reducer; EyeGate Pharmaceuticals Shares Plummet,2019-12-31 12:09:00-05:00,NVCN,positive
928746.0,"Mid-Morning Market Update: Markets Mostly Flat; Seadrill Reports 3-Year, $199M Middle East Contract",2019-12-31 10:20:00-05:00,NVCN,neutral
928747.0,Neovasc shares are trading higher after the company submitted its premarket approval application to the FDA for its Neovasc Reducer product.,2019-12-31 08:57:00-05:00,NVCN,positive
928748.0,"Benzinga Pro's Top 5 Stocks To Watch For Tues., Dec. 31, 2019: AMZN, WBAI, NVCN, NIO, NVDA",2019-12-31 08:39:00-05:00,NVCN,positive
928749.0,Neovasc Higher By 160% After Submitting Approval Application For Neovasc Reducer,2019-12-31 07:56:00-05:00,NVCN,positive
928750.0,11 Healthcare Stocks Moving In Tuesday's Pre-Market Session,2019-12-31 07:52:00-05:00,NVCN,neutral
928751.0,15 Stocks Moving in Tuesday's Pre-Market Session,2019-12-31 07:31:00-05:00,NVCN,neutral
928752.0,Neovasc Reports Submission Of Premarket Approval Application For Neovasc Reducer,2019-12-31 07:01:00-05:00,NVCN,positive
928753.0,Neovasc Highlights That Neovasc Reducer Was Featured In National Geographic Magazine,2019-12-17 07:08:00-05:00,NVCN,neutral
928754.0,70 Biggest Movers From Yesterday,2019-12-12 06:31:00-05:00,NVCN,neutral
928755.0,80 Biggest Movers From Friday,2019-11-11 04:51:00-05:00,NVCN,neutral
928756.0,65 Stocks Moving In Friday's Mid-Day Session,2019-11-08 13:15:00-05:00,NVCN,neutral
928757.0,Neovasc Q3 Sales $500.5K Miss $1.16M Estimate,2019-11-07 16:09:00-05:00,NVCN,negative
928758.0,Neovasc Appoints Bill Little As Chief Operating Officer,2019-11-07 08:04:00-05:00,NVCN,neutral
928759.0,Neovasc Reports Will Provide Update On TF/TS Tiara Program At PCR Valves 2019,2019-11-05 07:55:00-05:00,NVCN,neutral
928760.0,"H.C. Wainwright Initiates Coverage On Neovasc with Buy Rating, Announces $9 Price Target",2019-10-24 07:14:00-04:00,NVCN,neutral
928761.0,63 Biggest Movers From Yesterday,2019-10-16 04:04:00-04:00,NVCN,neutral
928762.0,40 Stocks Moving In Tuesday's Mid-Day Session,2019-10-15 12:48:00-04:00,NVCN,neutral
928763.0,22 Healthcare Stocks Moving In Tuesday's Pre-Market Session,2019-10-15 08:04:00-04:00,NVCN,neutral
928764.0,Neovasc Announces Notice Of US Patent Granted For Tiara Transcatheter Device For Treatment Of Severe Mitral Regurgitation,2019-10-15 07:13:00-04:00,NVCN,negative
928765.0,71 Biggest Movers From Yesterday,2019-09-12 05:33:00-04:00,NVCN,neutral
928766.0,"Neovasc Reports European Society Of Cardiology Included Co.'s Reducer For Treatment Of Refractory Angina In European Practice Guidelines For Diagnosis, Mgmt. Of Chronic Coronary Syndromes",2019-09-03 08:58:00-04:00,NVCN,neutral
928767.0,Neovasc Receives Nasdaq Notification Regarding Minimum Market Value Deficiency,2019-08-22 08:55:00-04:00,NVCN,positive
928768.0,"The Daily Biotech Pulse: Glaukos To Buy Avedro, Mixed Adcom Vote For Gilead, Dynavax Offering",2019-08-08 07:11:00-04:00,NVCN,neutral
928769.0,42 Healthcare Stocks Moving In Wednesday's After-Market Session,2019-08-07 21:24:00-04:00,NVCN,neutral
928770.0,82 Biggest Movers From Friday,2019-08-05 05:40:00-04:00,NVCN,neutral
928771.0,60 Stocks Moving In Friday's Mid-Day Session,2019-08-02 13:43:00-04:00,NVCN,neutral
928772.0,USPTO Site Shows Patent For Neovasc Titled 'Methods and apparatus for engaging a valve prosthesis with tissue',2019-07-30 09:55:00-04:00,NVCN,positive
928773.0,"The Daily Biotech Pulse: European Cheer For Merck, Legal Victory For Coherus, Medpace Picks Up On Earnings",2019-07-30 07:00:00-04:00,NVCN,positive
928774.0,42 Stocks Moving In Monday's Mid-Day Session,2019-07-29 12:30:00-04:00,NVCN,neutral
928775.0,"The Daily Biotech Pulse: Setback For Bristol-Myers Squibb, Gemphire Explodes, Lilly's Nasal Low Blood Sugar Drug",2019-07-25 07:21:00-04:00,NVCN,negative
928776.0,"The Daily Biotech Pulse: Jounce Jumps On Licensing Deal, Regulus Hit With Partial Clinical Hold, Genomic Health Added to S&P SmallCap Index",2019-07-24 07:08:00-04:00,NVCN,neutral
928777.0,List of Companies Reaching Yearly Lows Tuesday,2019-07-23 14:58:00-04:00,NVCN,neutral
928778.0,"The Daily Biotech Pulse: Acadia Schizophrenia Drug Fails, Viveve Plummets, Eisai Gets Breakthrough Therapy Designation",2019-07-23 07:26:00-04:00,NVCN,negative
928779.0,"Neovasc Regains Compliance With Nasdaq Minimum Bid Price Rule, Resolving Last Remaining Outstanding Nasdaq Deficiency",2019-07-17 15:08:00-04:00,NVCN,positive
928780.0,Neovasc Offers Update On Reducer Program For Treatment Of Refractory Angina: Sees Beginning To Commercialize In US By Early 2020,2019-07-16 08:57:00-04:00,NVCN,neutral
928781.0,Neovasc Reports Will Participate In Round-Robin Study Evaluating Prosthetic Heart Valve hydrodynamic Performance Measurements Among 13 Leading Int'l. Labs,2019-07-15 16:21:00-04:00,NVCN,neutral
928782.0,UPDATE: FDA Has Recommended Neovasc Consider Potential Alternate Approaches Such As The Humanitarian Device Exemption Pathway For Class IV Refractory Angina Patients And/Or Alternate Clinical Trial Designs For A Broader Refractory Angina,2019-07-12 08:57:00-04:00,NVCN,positive
928783.0,Neovasc To Explore HDE Approval Pathway And Alternate Trial Designs For Reducer Following Guidance From FDA,2019-07-12 08:56:00-04:00,NVCN,positive
928784.0,"The Daily Biotech Pulse: Roche Presents Positive Hemlibra Data, Amgen's Tender Offer For Nuevolution Complete, Genmab Offering",2019-07-09 07:11:00-04:00,NVCN,positive
928785.0,Neovasc Reports Regained Compliance With Nasdaq Minimum Market Value Rule,2019-06-25 14:30:00-04:00,NVCN,positive
928786.0,Opko Health Shows 5% Stake In Neovasc,2019-06-13 08:40:00-04:00,NVCN,neutral
928787.0,Neovasc shares are trading higher after a 13D filing from Opko Health showed a 5% stake in the company.,2019-06-12 17:24:00-04:00,NVCN,positive
928788.0,Neovasc 13D Filing From Opko Health Shows 5% Stake,2019-06-12 16:35:00-04:00,NVCN,neutral
928789.0,Penny Stock Neovasc Rallies On Patent Abstract Filing,2019-06-11 15:30:00-04:00,NVCN,neutral
928790.0,"Neovasc Shares Turn Positive, Up 9% Over Last Few Mins, Up 4% For Session",2019-06-11 11:08:00-04:00,NVCN,positive
928791.0,"Neovasc Shares Unaffected In Mid-Day Trade Amid Circulation Of US PTO Abstract Dated Jun. 11, 2019 For 'Methods and apparatus for loading a prosthesis onto a delivery system' By Neovasc Tiara",2019-06-11 11:07:00-04:00,NVCN,positive
928792.0,Neovasc Says Nasdaq Is Continuing To Monitor Its Minimum Market Value Deficiency Following 10 Straight Business Days Above $35M,2019-06-07 13:37:00-04:00,NVCN,positive
928793.0,Neovasc shares are trading higher after the company announced an FDA sprint discussion for the Neovasc Reducer took place and another discussion about clinical strategy will be held on June 26.,2019-06-04 14:29:00-04:00,NVCN,positive
928794.0,Neovasc Says Further FDA Sprint Discussion About Clinical Strategy For Neovasc Reducer Will Be Held On June 26,2019-06-04 14:28:00-04:00,NVCN,neutral
928795.0,Neovasc Re-elects Six Board Members,2019-06-04 14:20:00-04:00,NVCN,neutral
928796.0,A Look At Benzinga Pro's Most-Searched Tickers For May 24,2019-05-24 12:50:00-04:00,NVCN,neutral
928797.0,"Benzinga Pro's Top 10 Most-Searched Tickers For Morning of Fri., May 24, 2019",2019-05-24 10:49:00-04:00,NVCN,positive
928798.0,48 Biggest Movers From Yesterday,2019-05-24 05:10:00-04:00,NVCN,neutral
928799.0,"A Look At Benzinga Pro's Top 10 Most-Searched Tickers For May 23, 2019",2019-05-23 15:41:00-04:00,NVCN,positive
928800.0,Mid-Afternon Market Update: L Brands Rises After Q1 Results; Bluegreen Vacations Shares Plummet,2019-05-23 14:28:00-04:00,NVCN,positive
928801.0,Mid-Day Market Update: Crude Oil Down Over 5%; S&W Seed Shares Spike Higher,2019-05-23 12:45:00-04:00,NVCN,negative
928802.0,33 Stocks Moving In Thursday's Mid-Day Session,2019-05-23 12:32:00-04:00,NVCN,neutral
928803.0,Mid-Morning Market Update: Markets Open Lower; Best Buy Profit Tops Expectations,2019-05-23 10:33:00-04:00,NVCN,positive
928804.0,"Benzinga Pro's Top 10 Most-Searched Tickers For Morning of Thur., May 23, 2019",2019-05-23 10:21:00-04:00,NVCN,positive
928805.0,"Neovasc shares trading higher on continued momentum following news 2-year follow-up safety, efficacy data for its Neovasc Reducer was published in the International Journal of Cardiology.",2019-05-23 08:38:00-04:00,NVCN,positive
928806.0,25 Stocks Moving In Thursday's Pre-Market Session,2019-05-23 08:01:00-04:00,NVCN,neutral
928807.0,"The Daily Biotech Pulse: Breakthrough Therapy Designation For Iovance, Guardant Prices Offering, 2 Stocks to Debut",2019-05-23 07:37:00-04:00,NVCN,neutral
928808.0,"Neovasc shares trading higher following news 2-year follow-up safety, efficacy data for its Neovasc Reducer was published in the International Journal of Cardiology.",2019-05-22 17:50:00-04:00,NVCN,positive
928809.0,"Neovasc Reports 2-Year Follow-Up Safety, Efficacy Data For Neovasc Reduce In International Journal of Cardiology; Showed Sustained Therapeutic Effect At 2 Years Across Large Population",2019-05-22 17:45:00-04:00,NVCN,positive
928810.0,'Safety and efficacy of Coronary Sinus Reducer implantation at 2-year follow-up' -International Journal Of Cardiology,2019-05-21 11:11:00-04:00,NVCN,positive
928811.0,Neovasc Announces Private Placement Of Convertible Debt And Equity For Gross Proceeds Of $11.5M,2019-05-14 07:09:00-04:00,NVCN,negative
928812.0,"Neovasc Inc. - Common Shares Q1 EPS $(0.21) Misses $(0.05) Estimate, Sales $585.793K Miss $1.16M Estimate",2019-05-09 16:24:00-04:00,NVCN,negative
928813.0,48 Stocks Moving In Thursday's Mid-Day Session,2019-04-18 12:48:00-04:00,NVCN,neutral
928814.0,Neovasc shares are trading higher after the company announced the resolution of patent litigation claims by Edwards Lifesciences.,2019-04-17 15:45:00-04:00,NVCN,positive
928815.0,Neovasc Announces Resolution of Last Remaining Active Litigation,2019-04-17 15:44:00-04:00,NVCN,positive
928816.0,Neovasc Highlights Peer-Reviewed Publication International Journal of Cardiology Showing Neovasc Reducer™ Improves Diastolic Function In Patients Suffering From Severe Angina,2019-04-17 07:52:00-04:00,NVCN,negative
928817.0,"The Daily Biotech Pulse: Blueprint Medicine Expedites Clinical Programs, Eyepoint Offering, Precision Biosciences IPO",2019-03-28 07:54:00-04:00,NVCN,neutral
928818.0,Neovasc shares are trading lower after the company reported FY18 EPS decreased from last year.,2019-03-22 13:02:00-04:00,NVCN,neutral
928819.0,Neovasc FY18 EPS $(7.63) vs $(0.28) YoY,2019-03-21 16:04:00-04:00,NVCN,neutral
928820.0,48 Stocks Moving In Thursday's Mid-Day Session,2019-03-21 12:56:00-04:00,NVCN,neutral
928821.0,Neovasc shares are trading higher after the company won a patent dispute in a German court in which Edwards Lifesciences claimed co-inventorship for Newovasc's Tiara.,2019-03-21 08:57:00-04:00,NVCN,positive
928822.0,Neovasc's Reducer Featured In Presentation At American College Of Cardiology's Annual Meeting,2019-03-19 07:51:00-04:00,NVCN,neutral
928823.0,Neovasc Reports Completion Of Successful Quality System Surveillance Audit,2019-03-14 16:02:00-04:00,NVCN,positive
928824.0,68 Biggest Movers From Yesterday,2019-03-14 05:22:00-04:00,NVCN,neutral
928825.0,48 Stocks Moving In Wednesday's Mid-Day Session,2019-03-13 12:41:00-04:00,NVCN,neutral
928826.0,Neovasc shares are trading lower after the company priced an 11.11 million share common stock offering at $0.45 per share.,2019-03-13 09:46:00-04:00,NVCN,positive
928827.0,40 Stocks Moving In Wednesday's Pre-Market Session,2019-03-13 08:10:00-04:00,NVCN,neutral
928828.0,"The Daily Biotech Pulse: AEterna Zentaris Explores Options, Verastem Plunges On Weak Copiktra Sales, FDA Nod For Aerie",2019-03-13 07:27:00-04:00,NVCN,negative
928829.0,"Neovasc Prices ~11.11M Share Common Stock Offering At $0.45/Share, Total $5M",2019-03-13 06:22:00-04:00,NVCN,positive
928830.0,"7 Stocks To Watch For March 13, 2019",2019-03-13 05:34:00-04:00,NVCN,neutral
928831.0,Neovasc shares are trading lower after the company announced a proposed stock offering of common shares with no size disclosed.,2019-03-12 16:26:00-04:00,NVCN,neutral
928832.0,"Neovasc Reports Offering Of Common Shares, No Size Disclosed",2019-03-12 16:01:00-04:00,NVCN,neutral
928833.0,Neovasc Reports Deals To Exchange Outstanding Warrants For Shares,2019-03-12 09:15:00-04:00,NVCN,positive
928834.0,"Neovasc Announces That Its Tiara Transcatheter Mitral Valve Replacement Device Was Featured In An Update Presentation At The Cardiovascular Research Technologies Meeting Being Held March 2-5, 2019 In Washington, Dc",2019-03-04 13:06:00-05:00,NVCN,neutral
928835.0,72 Biggest Movers From Yesterday,2019-02-27 04:55:00-05:00,NVCN,neutral
928836.0,54 Stocks Moving In Tuesday's Mid-Day Session,2019-02-26 12:18:00-05:00,NVCN,neutral
928837.0,Mid-Day Market Update: Telaria Surges After Strong Q4 Results; Neovasc Shares Slide,2019-02-26 12:04:00-05:00,NVCN,positive
928838.0,Mid-Morning Market Update: Markets Edge Lower; Macy's Earnings Top Estimates,2019-02-26 10:11:00-05:00,NVCN,negative
928839.0,Neovasc shares are trading lower after the company announced a $5 million stock offering at $0.45 per share.,2019-02-26 09:17:00-05:00,NVCN,positive
928840.0,Neovasc Prices 11.11M Share Offering At $0.45/Share,2019-02-26 06:03:00-05:00,NVCN,positive
928841.0,Neovasc shares are trading lower after the company reported a common share offering with no disclosed size.,2019-02-25 17:10:00-05:00,NVCN,neutral
928842.0,"Neovasc Reports Offering Of Common Shares, No Size Disclosed",2019-02-25 16:46:00-05:00,NVCN,neutral
928843.0,"Neovasc Late Friday Announced Refiling Of Interim Financial Statements And Management's Discussion And Analysis For Period Ended September 30, 2018",2019-02-24 22:01:00-05:00,NVCN,neutral
928844.0,Neovasc Provides Corporate Update Discussing Resolution Of Litigation With MID; Co. Entered Settlement Agreement With MID,2019-02-20 07:34:00-05:00,NVCN,positive
928845.0,Neovasc Offers 5 Corporate Updates,2019-02-20 07:31:00-05:00,NVCN,neutral
928846.0,Neovasc Reports Renewal Of German NUB Status 1 Designation For Neovasc Reducer™ Procedure For Treatment of Refractory Angina,2019-01-30 07:35:00-05:00,NVCN,neutral
928847.0,Neovasc Receives Approval To Proceed With Phase 2 of TIARA-II Study From Clinical Regulators In Germany And UK,2019-01-29 07:31:00-05:00,NVCN,positive
928848.0,55 Biggest Movers From Yesterday,2019-01-23 05:19:00-05:00,NVCN,neutral
928849.0,Mid-Afternoon Market Update: Dow Down Over 400 Points; UQM Technologies Shares Spike Higher,2019-01-22 14:44:00-05:00,NVCN,positive
928850.0,50 Stocks Moving In Tuesday's Mid-Day Session,2019-01-22 12:21:00-05:00,NVCN,neutral
928851.0,Mid-Morning Market Update: Markets Open Lower; Johnson & Johnson Profit Tops Expectations,2019-01-22 10:17:00-05:00,NVCN,positive
928852.0,Neovasc shares are trading higher after the company announced dismissal of a patent infringement claim by Edwards Lifesciences.,2019-01-22 09:37:00-05:00,NVCN,negative
928853.0,Neovasc Announces Dismissal Of Claim brought By Edwards Lifesciences,2019-01-22 07:32:00-05:00,NVCN,neutral
928854.0,Neovasc Receives NASDAQ Notification Regarding Minimum Bid Price Deficiency,2019-01-14 16:33:00-05:00,NVCN,neutral
928855.0,Neovasc Receives Nasdaq Notification Regarding Minimum Market Value Deficiency,2019-01-03 19:54:00-05:00,NVCN,positive
928856.0,Neovasc shares are trading higher after the company received ISO 13485:2016 certification.,2018-12-21 16:17:00-05:00,NVCN,positive
928857.0,Neovasc Shares Halted On Circuit Breaker,2018-12-21 15:30:00-05:00,NVCN,positive
928858.0,Neovasc Receives ISO 13485: 2016 Certification,2018-12-21 15:17:00-05:00,NVCN,neutral
928859.0,"The Daily Biotech Pulse: Pfizer-Glaxo Set Up Consumer Health Care Venture, New Patent For Adamas",2018-12-19 07:46:00-05:00,NVCN,positive
928860.0,"The Daily Biotech Pulse: Puma Aces Late-Stage Trial, Chinese Cheer For FibroGen, J&J $5B Buyback Plan",2018-12-18 08:00:00-05:00,NVCN,positive
928861.0,"Stocks Which Set New 52-Week Low Yesterday, Thurs., Dec. 13, 2018",2018-12-14 11:03:00-05:00,NVCN,negative
928862.0,"The Daily Biotech Pulse: Axovant In-Licenses 2 Gene Therapies, Agile To Undertake Additional Study Of Contraceptive Patch",2018-12-14 07:47:00-05:00,NVCN,neutral
928863.0,Neovasc Announces Publication Of 12-year Follow-up Data For Neovasc Reducer As Published In JACC,2018-12-11 07:35:00-05:00,NVCN,neutral
928864.0,"Stocks Which Set New 52-Week Low Yesterday, Wed., Nov. 28, 2018",2018-11-29 10:59:00-05:00,NVCN,negative
928865.0,"The Daily Biotech Pulse: Twist In Protagonist Tale, Catalyst's Autoimmune Disorder Drug Approved",2018-11-29 08:09:00-05:00,NVCN,neutral
928866.0,"Stocks Which Set New 52-Week Low Yesterday Tues., Nov. 27, 2018",2018-11-28 11:54:00-05:00,NVCN,negative
928867.0,"Stocks Which Set New 52-Week Low Yesterday, Mon., Nov. 26, 2018",2018-11-27 11:26:00-05:00,NVCN,negative
928868.0,"The Daily Biotech Pulse: Abeona Fires CEO, Loxo Passes FDA Muster, Bristol-Myers Flunks Lung Cancer Trial",2018-11-27 07:32:00-05:00,NVCN,negative
928869.0,"Stocks Which Set New 52-Week Low The Prior Trading Session, Fri., Nov. 23, 2018",2018-11-26 10:44:00-05:00,NVCN,negative
928870.0,"Stocks Which Set New 52-Week Low Yesterday, Tues., Nov. 20, 2018",2018-11-21 08:50:00-05:00,NVCN,negative
928871.0,"The Daily Biotech Pulse: Mylan Recalls Blood Pressure Drug, Heat Biologics Offering, New Novelion CEO",2018-11-21 08:04:00-05:00,NVCN,negative
928872.0,"Stocks Which Set New 52-Week Low Yesterday, Mon., Nov. 19, 2018",2018-11-20 09:12:00-05:00,NVCN,negative
928873.0,"The Daily Biotech Pulse: Denali's Positive Results, Novartis' Substance Abuse Therapy Launch, Medtronic Earnings",2018-11-20 08:29:00-05:00,NVCN,negative
928874.0,"The Daily Biotech Pulse: Mallinckrodt FDA Verdict, European Cheer For Bristol-Myers Squibb, Morphosys Clinches Licensing Deal",2018-11-16 08:08:00-05:00,NVCN,positive
928875.0,64 Biggest Movers From Yesterday,2018-11-16 04:58:00-05:00,NVCN,neutral
928876.0,45 Stocks Moving In Thursday's Mid-Day Session,2018-11-15 12:38:00-05:00,NVCN,neutral
928877.0,"Stocks Which Set New 52-Week Low Yesterday, Wed., Nov. 14, 2018",2018-11-15 11:37:00-05:00,NVCN,negative
928878.0,"The Daily Biotech Pulse: FDA Nod For Mallinckrodt's Pain Drug, AbbVie-Neurocrine Report Positive Elagolix Results",2018-11-15 08:10:00-05:00,NVCN,positive
928879.0,34 Stocks Moving In Thursday's Pre-Market Session,2018-11-15 08:02:00-05:00,NVCN,neutral
928880.0,Neovasc shares down 18% following worse-than-expected Q3 results,2018-11-14 18:03:00-05:00,NVCN,positive
928881.0,"Neovasc Inc. Q3 EPS $(0.70) May Not Compare To $(0.05) Estimate, Sales $480.54K Miss $1.16M Estimate",2018-11-14 16:01:00-05:00,NVCN,negative
928882.0,Neovasc Q3 Earnings Preview,2018-11-14 08:03:00-05:00,NVCN,neutral
928883.0,75 Biggest Movers From Yesterday,2018-11-07 04:00:00-05:00,NVCN,neutral
928884.0,"Stocks Which Set New 52-Week Low Yesterday, October 31st",2018-11-01 10:37:00-04:00,NVCN,negative
928885.0,"The Daily Biotech Pulse: AbbVie's Leukemia Drug Trial Meets Endpoint, Denali Strikes Collaboration Deal",2018-11-01 07:30:00-04:00,NVCN,negative
928886.0,Neovasc Broadcasts Surgery With Mitral Valve Device Live At Medical Conference,2018-10-23 10:43:00-04:00,NVCN,neutral
928887.0,"Stocks Which Set New 52-Week Low Yesterday, October 22nd",2018-10-23 09:54:00-04:00,NVCN,negative
928888.0,Neovasc shares are trading higher after its Tiara transcatheter replacement device was featured in a live case broadcast at the European Association for Cardio-Thoracic Surgery.,2018-10-23 08:52:00-04:00,NVCN,positive
928889.0,"The Daily Biotech Pulse: Regulus Soars On Positive Pre-Clinical Data, Biogen Earnings, Proteostasis And Eiger to Offer Shares",2018-10-23 08:35:00-04:00,NVCN,positive
928890.0,21 Stocks Moving In Tuesday's Pre-Market Session,2018-10-23 08:33:00-04:00,NVCN,neutral
928891.0,Neovasc Reports Its Tiara Transcatheter Mitral Valve Replacement Device Was Featured In A Live Case Broadcast At European Association for Cardio-Thoracic Surgery Meeting,2018-10-22 16:33:00-04:00,NVCN,neutral
928892.0,41 Biggest Movers From Yesterday,2018-10-11 05:22:00-04:00,NVCN,neutral
928893.0,"10 Hottest Stocks From October 10, 2018",2018-10-10 17:18:00-04:00,NVCN,neutral
928894.0,"Benzinga Pro's Top 10 Most-Searched Tickers For Afternoon Of Wed., Oct. 10, 2018",2018-10-10 16:25:00-04:00,NVCN,positive
928895.0,41 Stocks Moving In Wednesday's Mid-Day Session,2018-10-10 12:54:00-04:00,NVCN,neutral
928896.0,Mid-Day Market Update: Crude Oil Down Over 2%; Esterline Technologies Shares Spike Higher,2018-10-10 12:08:00-04:00,NVCN,negative
928897.0,"Neovasc shares are trading up 27.7% after the company's Reducer, a treatment for refractory angina, was granted Breakthrough Device Designation by the FDA.",2018-10-10 11:11:00-04:00,NVCN,positive
928898.0,"Benzinga Pro's Top 10 Most-Searched Tickers For Morning Of Wed., Oct. 10, 2018",2018-10-10 11:07:00-04:00,NVCN,positive
928899.0,Mid-Morning Market Update: Markets Open Lower; TransDigm To Buy Esterline,2018-10-10 10:37:00-04:00,NVCN,negative
928900.0,30 Stocks Moving In Wednesday's Pre-Market Session,2018-10-10 08:02:00-04:00,NVCN,neutral
928901.0,"Shares of Neovasc are trading higher after the company's medical device was granted ""breakthrough device designation"" by the FDA.",2018-10-10 07:37:00-04:00,NVCN,positive
928902.0,Neovasc Reducer Granted Breakthrough Device Designation By FDA,2018-10-10 07:34:00-04:00,NVCN,positive
928903.0,Neovasc Regains Compliance with Nasdaq Minimum Bid Price Rule,2018-10-09 14:05:00-04:00,NVCN,neutral
928904.0,55 Biggest Movers From Yesterday,2018-10-04 05:29:00-04:00,NVCN,neutral
928905.0,43 Stocks Moving In Wednesday's Mid-Day Session,2018-10-03 13:09:00-04:00,NVCN,neutral
928906.0,Neovasc shares are trading up 28% after the company announced 12-week data from the first US patient implanted with a Neovasc reducer; The patient exhibited improvement in walking abilities and reduced pain.,2018-10-03 11:31:00-04:00,NVCN,positive
928907.0,Mid-Morning Market Update: Markets Open Higher; Lennar Earnings Top Expectations,2018-10-03 10:16:00-04:00,NVCN,positive
928908.0,25 Stocks Moving In Wednesday's Pre-Market Session,2018-10-03 08:10:00-04:00,NVCN,neutral
928909.0,Neovasc Announces 12-week Follow-up Data From The First U.S. Patient Implanted With A Neovasc Reducer; Patient Reported Improvement In Walking Abilities And Decreased Pain,2018-10-03 07:35:00-04:00,NVCN,positive
928910.0,30 Stocks Moving In Thursday's Pre-Market Session,2018-09-27 08:10:00-04:00,NVCN,neutral
928911.0,51 Biggest Movers From Yesterday,2018-09-26 05:17:00-04:00,NVCN,neutral
928912.0,6 Stocks Moving In Tuesday's After-Hours Session,2018-09-25 17:08:00-04:00,NVCN,neutral
928913.0,24 Stocks Moving In Monday's Pre-Market Session,2018-09-24 08:27:00-04:00,NVCN,neutral
928914.0,REMINDER: Neovasc 1-For-100 Reverse Split Effective Today,2018-09-21 05:56:00-04:00,NVCN,positive
928915.0,"Stocks Which Set New 52-Week Low Yesterday, September 17th",2018-09-18 09:27:00-04:00,NVCN,negative
928916.0,"The Daily Biotech Pulse: Morphosys Expands Collaboration, Osiris Announces Product Launch, Argenx To Offer Shares",2018-09-18 08:44:00-04:00,NVCN,positive
928917.0,"The Week Ahead: Alibaba Investor Day, FedEx Earnings, Eventbrite IPO",2018-09-17 14:46:00-04:00,NVCN,neutral
928918.0,"Stocks Which Set New 52-Week Low Yesterday, September 13th",2018-09-14 09:30:00-04:00,NVCN,negative
928919.0,"Neovasc Announces Extension to Regain Compliance with Nasdaq Minimum Bid Price Rule, Co. To Execute 1-for-100 Reverse Stock Split",2018-09-11 07:32:00-04:00,NVCN,neutral
928920.0,"Neovasc Comments On Lawsuit Filed By Endovalve Inc. And Micro Interventional Devices, Inc.; Says It Intends To 'vigorously Defend Itself' I Plaintiffs Serve Complaint",2018-09-11 07:22:00-04:00,NVCN,negative
928921.0,"Neovasc Inc. - Common Shares Q2 EPS $(0.04) Beats $(0.05) Estimate, Sales $405.241K Miss $1.16M Estimate",2018-08-08 17:05:00-04:00,NVCN,positive
928922.0,Neovasc shares are trading up 18.1% after safety and efficacy results from the company's REDUCE study were published in the International Journal of Cardiology.,2018-08-06 12:09:00-04:00,NVCN,positive
928923.0,Neovasc Announces Publication Of Safety And Efficacy Results From REDUCE Study In International Journal Of Cardiology,2018-08-06 07:38:00-04:00,NVCN,positive
928924.0,Nasdaq To Hold Hearing To Consider Neovasc's Delisting Determination Appeal,2018-07-16 16:31:00-04:00,NVCN,positive
928925.0,Neovasc Announces Filing of 'Administrative' Prospectus Supplement Relating to Expiry of Prior Shelf Prospectus / Registration Statement,2018-07-16 07:05:00-04:00,NVCN,neutral
928926.0,Neovasc Announces First Implant Of A Neovasc Reducer In A U.S. Patient,2018-06-20 07:31:00-04:00,NVCN,neutral
928927.0,Neovasc Names Steve Rubin Chair,2018-06-11 07:32:00-04:00,NVCN,neutral
928928.0,Neovasc Offers Highlights From EuroPCR Symposium,2018-05-25 07:33:00-04:00,NVCN,neutral
928929.0,Neovasc's Management and Board of Directors Urge Shareholders to Vote In Favor of the Proposed Reverse Stock Split at the Upcoming Annual General and Special Meeting of Shareholders,2018-05-15 07:31:00-04:00,NVCN,positive
928930.0,Neovasc Shares Down 18.8% After Hours Following Q1 Miss,2018-05-10 17:51:00-04:00,NVCN,positive
928931.0,"Neovasc Inc Q1 EPS $(0.38) Misses $(0.05) Estimate, Sales $339.922K Miss $1.16M Estimate",2018-05-10 17:31:00-04:00,NVCN,negative
928932.0,Neovasc Regains Compliance with Nasdaq Minimum Market Value Rule,2018-05-10 14:01:00-04:00,NVCN,positive
928933.0,Neovasc Announces Receipt of US$7.1 Million from Exercise of Series C Warrants,2018-04-11 16:32:00-04:00,NVCN,neutral
928934.0,Neovasc Shares Down 14.6% In After-Hours Trading Following Larger-Than-Expected FY17 Miss,2018-03-28 16:13:00-04:00,NVCN,positive
928935.0,"Neovasc Reports FY17 EPS $(0.28) Misses $(0.26) Est., Sales $1.128M vs $1.004M In Prior Year",2018-03-28 16:03:00-04:00,NVCN,negative
928936.0,Neovasc Receives Nasdaq Notification Regarding Minimum Market Value Deficiency,2018-03-23 16:30:00-04:00,NVCN,positive
928937.0,Neovasc Announces Fed Colen CEO,2018-01-22 07:04:00-05:00,NVCN,neutral
928938.0,Neovasc Earlier Reported Tiara's Clinical Case Load Accelerating,2018-01-08 11:17:00-05:00,NVCN,neutral
928939.0,Neovasc Reports Received NASDAQ Notification Related To Minimum Bid Requirements,2018-01-02 17:00:00-05:00,NVCN,neutral
928940.0,Capital World Investors Reports 13.8% Stake In Neovasc,2017-12-11 11:37:00-05:00,NVCN,neutral
928941.0,"Neovasc Reports Q3 EPS $(0.06) vs. $(0.07) Est., Revemie $1.3M vs. $1.8M Est.",2017-11-14 17:01:00-05:00,NVCN,neutral
928942.0,Neovasc Prices ~6.6M Unit Offering @$1.46/Unit,2017-11-10 04:29:00-05:00,NVCN,neutral
928943.0,Neovasc Reports Received FDA Approval To Initiate Pivotal Reducer Trial,2017-11-06 07:09:00-05:00,NVCN,positive
928944.0,"UPDATE: Neovasc Will Evaluate All Options Available Relating To Requirement To Pay Damages And Fund The Remaining $52M Not Held in Escrow, Which Exceeds Co.'s Current Cash Resources",2017-11-03 14:48:00-04:00,NVCN,negative
928945.0,"Neovasc Provides Litigation Update, U.S. Court Of Appeals Affirmed Judgement In Case Of CardiAQ Valve Tech vs Neovasc; Full Judgement Is ~$112M, Of Which Neovasc Has ~$70M In Escrow",2017-11-03 14:47:00-04:00,NVCN,negative
928946.0,Neovasc Offers Clinical Update On Tiara: 'technical success rate in these implantations is 31/34 or 91.1%',2017-09-12 07:07:00-04:00,NVCN,positive
928947.0,Spike In Neovasc Shares Being Attributed By Traders To Unconfirmed Positive Sell-Side Comments,2017-09-05 15:12:00-04:00,NVCN,positive
928948.0,Neovasc's Reducer System is Reviewed in the European Heart Journal,2017-09-05 07:09:00-04:00,NVCN,neutral
928949.0,"Neovasc Reports Decision from Appeals Court That Upholds Lower Court Decisions, But Denies Injunction; Neovasc Must Pay Full Judgement of $112M Of Which ~$70M Is Already Held In Escrow",2017-09-01 12:28:00-04:00,NVCN,negative
928950.0,Neovasc Halted News Pending,2017-09-01 10:06:00-04:00,NVCN,neutral
928951.0,"Neovasc Reports EPS $($0.07) In-line With Est., Sales $1.305M vs$1.63M Est.",2017-08-10 16:01:00-04:00,NVCN,neutral
928952.0,"Neovasc Shares Resume Trade, Down 20%",2017-06-16 11:15:00-04:00,NVCN,positive
928953.0,UPDATE: Neovasc Reports District Court In Munich Partially Found In Favor Of Edwards Lifesciences,2017-06-16 10:47:00-04:00,NVCN,positive
928954.0,Neovasc Reports German Court Ruling,2017-06-16 10:46:00-04:00,NVCN,neutral
928955.0,Neovasc Shares Halted News Pending,2017-06-16 09:36:00-04:00,NVCN,positive
928956.0,22 Biggest Mid-Day Losers For Thursday,2017-05-11 12:47:00-04:00,NVCN,negative
928957.0,"Neovasc Reports Q1 EPS $(0.10) vs $(0.08) Est., Sales $1.481M vs $2.63M Est.",2017-05-10 16:00:00-04:00,NVCN,neutral
928958.0,"Neovasc Shares Spike to Session Highs, Now Up 12.9%; Hearing Ladenburg Thalmann Issued Mid-Day Upgrade to Buy",2017-04-05 12:48:00-04:00,NVCN,positive
928959.0,Neovasc Shares Indicated ~11% Higher; Hearing JMP Has Suggested Co. Could be Purchased by Boston Scientific,2017-03-31 09:18:00-04:00,NVCN,positive
928960.0,UPDATE: Neovasc Reports Q4 Sales $2.75M vs. $2.63M Est.,2017-03-23 16:20:00-04:00,NVCN,neutral
928961.0,"Neovasc Reports FY16 EPS $(1.28) vs. $(0.41) YoY, Sales $1M vs. $526K YoY",2017-03-23 16:01:00-04:00,NVCN,neutral
928962.0,"Earnings Scheduled For March 23, 2017",2017-03-23 04:20:00-04:00,NVCN,neutral
928963.0,Neovasc Pops to High of $1.96 on Volume,2017-03-20 09:33:00-04:00,NVCN,neutral
928964.0,"Neovasc Reports Update in Litigation with CardiAQ, Co. Intends To Seek Expedited Appeal Of Judgement, Including Underlying Damages Awarded",2017-01-18 14:05:00-05:00,NVCN,negative
928965.0,"Neovasc Shares Spike To $1.96, Now Up 8.67% At $1.90",2017-01-04 09:56:00-05:00,NVCN,positive
928966.0,Why Neovasc Shares Could Move Meaningfully Higher As Path Through Litigation Becomes Clearer,2016-12-27 10:40:00-05:00,NVCN,positive
928967.0,"Neovasc Shares Resume Trade, Now Up 1%",2016-12-23 12:50:00-05:00,NVCN,positive
928968.0,Neovasc Shares to Resume Trade at 12:50 p.m. EST,2016-12-23 12:37:00-05:00,NVCN,positive
928969.0,"Neovasc Announces Update in Litigation with CardiAQ Will Deposit $70M In Joint Escrow Account And Enter General Security Agreement, Grants Stay Of Judgement Pending Completion of Appeal",2016-12-23 12:30:00-05:00,NVCN,positive
928970.0,Neovasc Halted News Pending,2016-12-23 12:09:00-05:00,NVCN,neutral
928971.0,Neovasc Spikes to High of $1.99 on Volume,2016-12-20 11:38:00-05:00,NVCN,neutral
928972.0,Boston Scientific Reports 15% Passive Stake in Neovasc in 13G,2016-12-16 06:14:00-05:00,NVCN,positive
928973.0,18 Biggest Mid-Day Losers For Wednesday,2016-12-14 12:56:00-05:00,NVCN,negative
928974.0,Mid-Afternoon Market Update: Dow Rises Over 100 Points; Proteon Therapeutics Shares Slide,2016-12-13 14:33:00-05:00,NVCN,positive
928975.0,10 Biggest Mid-Day Gainers For Tuesday,2016-12-13 12:42:00-05:00,NVCN,neutral
928976.0,Mid-Day Market Update: Inovalon Drops After Lowered Outlook; Achaogen Shares Surge,2016-12-13 12:26:00-05:00,NVCN,positive
928977.0,Mid-Morning Market Update: Markets Open Higher; VeriFone Issues Weak Forecast,2016-12-13 09:51:00-05:00,NVCN,negative
928978.0,20 Stocks Moving In Tuesday's Pre-Market Session,2016-12-13 08:30:00-05:00,NVCN,neutral
928979.0,Boston Scientific to Acquire Certain Neovasc Assets and 15% Equity for $75M,2016-12-13 07:09:00-05:00,NVCN,positive
928980.0,18 Biggest Mid-Day Losers For Wednesday,2016-12-07 13:03:00-05:00,NVCN,negative
928981.0,Legal Overhangs Keep Ladenburg Neutral On Neovasc Despite Positive Tiara Clinical Data,2016-12-07 11:43:00-05:00,NVCN,negative
928982.0,Neovasc Shares Down 14.87% Early On Heavy Volume; Ladenburg Analysts Today Reiterated Neutral Rating Citing Legal Overhangs,2016-12-07 10:34:00-05:00,NVCN,positive
928983.0,20 Stocks Moving In Wednesday's Pre-Market Session,2016-12-07 08:28:00-05:00,NVCN,neutral
928984.0,Neovasc Shares Close Up 70% Tuesday Amid Morning Data Release on Tiara Mitral Valve; Shares Up Nearly 400% Since Fri. When Boston Scientific Announced Deal to Buy 15% Stake in Co.,2016-12-06 17:15:00-05:00,NVCN,positive
928985.0,Mid-Afternoon Market Update: U.S. Stocks Edge Higher; Intralinks Shares Climb On Acquisition News,2016-12-06 14:26:00-05:00,NVCN,positive
928986.0,18 Biggest Mid-Day Gainers For Tuesday,2016-12-06 12:23:00-05:00,NVCN,neutral
928987.0,Mid-Day Market Update: Crude Oil Down 2%; Francesca's Shares Rise On Earnings Beat,2016-12-06 12:03:00-05:00,NVCN,negative
928988.0,Mid-Morning Market Update: Markets Mostly Flat; AutoZone Profit Tops Views,2016-12-06 10:05:00-05:00,NVCN,positive
928989.0,Neovasc Provides Update on its Tiara Mitral Valve Clinical Program,2016-12-06 07:03:00-05:00,NVCN,neutral
928990.0,Mid-Afternoon Market Update: Crude Oil Up 1%; Five Below Shares Rise On Earnings Beat,2016-12-02 14:26:00-05:00,NVCN,negative
928991.0,15 Biggest Mid-Day Gainers For Friday,2016-12-02 12:41:00-05:00,NVCN,neutral
928992.0,Mid-Day Market Update: Smith & Wesson Declines On Weak Forecast; Envision Healthcare Shares Spike Higher,2016-12-02 12:15:00-05:00,NVCN,negative
928993.0,Mid-Morning Market Update: Markets Mixed; Big Lots Earnings Beat Estimates,2016-12-02 09:50:00-05:00,NVCN,neutral
928994.0,25 Stocks Moving In Friday's Pre-Market Session,2016-12-02 08:26:00-05:00,NVCN,neutral
928995.0,Neovasc Shares Rise 100% Following Announcement of Agreement with Boston Scientific,2016-12-02 07:40:00-05:00,NVCN,positive
928996.0,Boston Scientific Announces Agreement to Acquire Neovasc Advanced Biological Tissue Capabilities For $75M In Cash; Includes 15% Equity Investment In Neovasc,2016-12-02 07:01:00-05:00,NVCN,positive
928997.0,Neovasc Shares Halted News Pending,2016-12-02 06:58:00-05:00,NVCN,positive
928998.0,Neovasc Receives Regulatory Approval to Initiate TIARA II CE Mark Study,2016-11-28 07:02:00-05:00,NVCN,positive
928999.0,Neovasc Gets Approval for Italian TIARA II Study,2016-11-28 07:01:00-05:00,NVCN,positive
929000.0,Neovasc Announces Dismissal of Class Action Lawsuit,2016-11-23 08:19:00-05:00,NVCN,negative
929001.0,"Neovasc Reports Q3 EPS $(0.44), Revenues $3.034M vs $2.2M Est",2016-11-14 16:16:00-05:00,NVCN,neutral
929002.0,18 Biggest Mid-Day Losers For Tuesday,2016-11-01 14:17:00-04:00,NVCN,negative
929003.0,Mid-Day Market Update: InspireMD Jumps Following Positive CGuard Results; Neovasc Shares Drop,2016-11-01 12:11:00-04:00,NVCN,positive
929004.0,Mid-Morning Market Update: Markets Edge Lower; Pfizer Profit Misses Views,2016-11-01 10:24:00-04:00,NVCN,negative
929005.0,Neovasc Resumes Trading -41% @ $0.60,2016-11-01 07:35:00-04:00,NVCN,neutral
929006.0,"Neovasc Announces Update in Litigation with CardiAQ, To Pay $91M In Damages",2016-11-01 07:29:00-04:00,NVCN,negative
929007.0,Neovasc to Resume Trading at 7:30 AM ET,2016-11-01 07:26:00-04:00,NVCN,neutral
929008.0,UPDATE: Neovasc Says Judge Denied Cardiaq's Motion For An Injunction That Would Have Shut Down Development Of Tiara,2016-11-01 07:08:00-04:00,NVCN,negative
929009.0,"Neovasc Says In Order, Judge Ruled In Favor Of Cardiaq On Issue Of Inventorship Of Neovasc's '964 Patent",2016-11-01 07:05:00-04:00,NVCN,positive
929010.0,Judge Orders Neovasc To Destroy Variety Of Information That CardiAQ Sent Between June 2009-April 2010,2016-10-31 15:33:00-04:00,NVCN,negative
929011.0,BZ NOTE: Neovasc Presenting Update On Tiara Transcatheter Mitral Valve Clinical Program At Transcatheter Cardiovascular Therapeutics Symposium Today,2016-10-31 15:28:00-04:00,NVCN,positive
929012.0,Neovasc Halted News Pending,2016-10-31 15:09:00-04:00,NVCN,neutral
929013.0,"Neovasc Reports Q2 EPS $(1.25) vs. Prior Year Quarter $(0.10), Rev. $1.7M vs. Prior Year Quarter $2.9M",2016-08-09 16:22:00-04:00,NVCN,neutral
929014.0,Neovasc Receives NASDAQ Notification Regarding Minimum Bid Requirements,2016-07-05 16:33:00-04:00,NVCN,neutral
929015.0,10 Biggest Mid-Day Gainers For Monday,2016-06-20 12:35:00-04:00,NVCN,neutral
929016.0,Mid-Day Market Update: Crude Oil Rises 2.5%; Epizyme Shares Drop,2016-06-20 12:11:00-04:00,NVCN,negative
929017.0,Mid-Morning Market Update: Markets Open Higher; Icahn Enterprises Raises Offer For Federal Mogul,2016-06-20 10:01:00-04:00,NVCN,neutral
929018.0,12 Stocks Moving In Monday's Pre-Market Session,2016-06-20 08:29:00-04:00,NVCN,neutral
929019.0,Neovasc Reveals Positive Results For Reducer System Treatment For Refractory Angina Published In Cardiology Journal,2016-06-20 08:23:00-04:00,NVCN,positive
929020.0,Neovasc +29% Premarket @$0.98;  Positive Results for Reducer System Treatment For Refractory Angina Published In Cardiology Journal,2016-06-20 07:35:00-04:00,NVCN,positive
929021.0,7 Biggest Mid-Day Losers For Friday,2016-05-20 12:13:00-04:00,NVCN,negative
929022.0,"Lawsuit Against Neovasc Comes Back In Favor Of CardiAQ; Ladenburg Thalmann Downgrades, Removes PT",2016-05-20 10:16:00-04:00,NVCN,positive
929023.0,Ladenburg Thalmann Downgrades Neovasc to Neutral,2016-05-20 07:16:00-04:00,NVCN,neutral
929024.0,Neovasc Announces Jury Verdict in Favor of CardiAQ,2016-05-19 19:33:00-04:00,NVCN,positive
929025.0,"Neovasc Q1 EPS ($0.16) vs ($0.12) est, Revenue $2.0M vs $3.3M est",2016-04-29 06:37:00-04:00,NVCN,neutral
929026.0,Benzinga's Top Initiations,2015-12-10 09:19:00-05:00,NVCN,positive
929027.0,"Ladenburg Thalmann Initiates Coverage on Neovasc at Buy, Announces $9.25 PT",2015-12-10 08:09:00-05:00,NVCN,neutral
929028.0,"Neovasc Reports Q3 EPS (C$0.15), no estimates",2015-11-09 06:04:00-05:00,NVCN,negative
929029.0,"JMP Securities Assumes Neovasc at Market Outperform, Announces $10.00 PT",2015-10-07 06:06:00-04:00,NVCN,positive
929030.0,"Neovasc Reports Q2 Loss C$0.12, Revs C$3.6M, no estimates",2015-08-06 07:08:00-04:00,NVCN,negative
929031.0,4 Biomedical Stocks Canaccord Loves,2015-05-26 12:46:00-04:00,NVCN,positive
929032.0,"Canaccord Genuity Initiates Coverage on Neovasc at Buy, Announces $15.00 PT",2015-04-02 07:33:00-04:00,NVCN,neutral
929033.0,Benzinga's Top Initiations,2015-03-31 08:54:00-04:00,NVCN,positive
929034.0,Northland Securities Initiates Neovasc With Outperform,2015-03-31 08:44:00-04:00,NVCN,positive
929035.0,"Northland Securities Initiates Coverage on Neovasc at Outperform, Announces $12.00 PT",2015-03-31 07:40:00-04:00,NVCN,positive
929036.0,"Leerink Swann Initiates Coverage on Neovasc at Outperform, A $25.00 PT",2015-03-20 09:31:00-04:00,NVCN,neutral
929037.0,"JMP Securities Initiates Coverage on Neovasc at Market Outperform, Announces $14.00 PT",2014-10-29 09:23:00-04:00,NVCN,positive
929038.0,"Neovasc Receives FDA Conditional Approval To Initiate TIARA-I Trial In US: A Multinational, Multicenter Early Feasibility Trial Of The Tiara Transcatheter Mitral Valve",2014-10-09 07:08:00-04:00,NVCN,positive
